Figure 4From: Cardiovascular benefits and safety profile of acarbose therapy in prediabetes and established type 2 diabetesMean systolic and diastolic blood pressure in patients with hypertension and type 2 diabetes treated with acarbose or glibenclamide for 6 months. Adapted with permission from Rosenthal & Mausersberger. [57]Back to article page